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expecteddeaths for patients at this level ofMELD/Child Pugh score.
There was also an increased risk of mortality in the intervention
group compared to the standard care group in the second half of
the trial. Additionally, themuch lower risk for the coordinated care
group in the ﬁrst 3 months followed by a higher risk indicates that
beneﬁts of the program were mostly achieved early on and were
therefore probably not strongly related to the total number of
visits/time spent with clinicians. Likewise, the unexpectedly high
death rate in the standard care group suggests either that the
standard care program provided was below the average standard
careprogram, that thepatients in this groupwere sicker in respects
to factors other than their MELD score, or perhaps that the group
allocation procedure lead standard care patients to amore delayed
treatment following discharge.
With respect to the data on readmissions, knowledge of the
unadjusted effects of the program, in addition to the adjusted
effects, would have been useful to determine if confounding
was present. The adjusted nature of the analysis, rather than a
simple unadjusted comparison, perhaps reﬂects the observa-
tional nature of the study since an RCT automatically eliminates
confounding from both known and unknown risk factors and
does not therefore require statistical adjustment. We were also
intrigued that although the analysis suggests an important effect
of the intervention, a surprising additional result was that several
known risk factors for readmission, including age and MELD,
were not independent predictors beyond the group allocation.
This suggests that the group allocation effect on readmission
was strongly associated with these variables. We highlight the
possibility that good coordinated care for sick patients may
generate an increase in emergency readmissions in the short
term, via improved access to care. This was an interesting
ﬁnding in our study [3] and has also been noted by other
investigators [4].
For new care models to be adopted in cirrhosis the evidence
base must be of the highest order, as it has been the case for other
diseases such as heart failure [5]. In the absence of high quality
evidence, the signiﬁcant upfront costs associated with re-orga-
nizing care along new models, are unlikely to be funded by
current health care systems. Although we believe instinctively
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To the Editor:
We would like to thank A.J. Wigg et al. for their interest in our
study about a new model of care coordination by consultant
hepatologists in outpatients with cirrhosis and ascites [1]. We
regret that the Editorialists have not considered their publica-
tion but, such is life! Moreover, it should be recognized that
the appearance of the two manuscripts on PubMed were very
close each to one other. In their letter [2] A.J. Wigg et al. high-
lighted once again that our study was not randomized and sug-
gested that the differences in outcomes of the two groups of
our work were not linked to the process of management as
outpatients, but to confounding factors that were not well bal-
anced between the two groups. The circumstance that our
study was not randomized has been already stressed by our-
selves and by the editorialists. We also set out to explain the
reasons why we decided to perform this type of study. As far
as the enrollment and the matching process are concerned,
as we stated in the paper, patients were enrolled consecutively
on discharge from hospitalization due to acute decompensation
of cirrhosis, and subjected to matching for a large number of
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ariables (age, gender, type of ascites, Model for End Stage
iver Disease (MELD) score, Child-Turcotte-Pugh (CTP) score,
tiology of cirrhosis, local or not local residences, and
o-morbidities evaluated with the Charlson index). Here, it
as clear that there were no signiﬁcant differences in terms
f baseline demographic, clinical or laboratory features. We
ecognize that the propensity score matching may probably
e better, but the sample size was too small for its application.
owever, patients started the assigned care management pro-
ram at the same time following discharge, as reported in
e results.
A.J. Wigg et al. have also speculated that there was a lack of
rocess measures performed during the study, for example,
egarding the patient’s attendance of scheduled appointments.
ur study was not speciﬁcally designed to evaluate the compli-
nce of patients, but rather to assess whether the new model
the Care Management Program’’, based on an integrated activity
f dedicated physicians and nurses and on some facilities such as
b examinations and diagnostic examinations in real time, may
prove some outcomes in patients with cirrhosis and ascites
s compared to the standard specialized caregiving model in
ur country. Nonetheless, the patients’ attendance of the sched-
led appointments was extremely high in both groups (>90%)
ith a dropout rate of 2%. This represents a huge difference
etween our study and that of A.J. Wigg et al., in which the rate
f drop out was considerably higher.
As regards the relationship between the outcomes and the
umber of specialist evaluations, it has been clearly reported that
e mean global number of specialist evaluations in the care
anagement program was almost double that in the standard
rogram, either when expressed per patient or per patient month
f life. We did not introduce this parameter in the univariate
nalysis because we thought and we continue to think that the
hilosophy of the new model is more relevant than the single
umbers or aspects of the model.
Looking to A.J. Wigg et al., they proposed an analysis about the
ming of mortality, assuming a too high rate of early and overall
ortality in patients followed with the standard of care. Regard-
g this, we must emphasize the importance of an early interven-
on in patients with cirrhosis and ascites discharged after a
ospitalization related to a complication of cirrhosis: they are a
opulation of frail patients, immunosuppressed and predisposed
wards new complications and hospital readmission [3]. Thus,
e prompt management of hyponatremia, renal failure and sub-
linical bacterial infections that was enabled in patients who
ere assigned to the ‘‘Care Management Program’’, can deﬁni-
vely account for the deﬁnition of an early difference in the sur-
ival curve compared to that of patients who were assigned to
e standard model. In addition, the standard treatment group
resented a mortality rate that is in line with that reported in
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management model fore literature on the natural history of cirrhosis, namely a rate
f 40% one year after the development of ascites [4]. As regards
e probability of hospital readmission, recently, M.L. Volk and
olleagues [3] have shown, in a similar type of patients, a one-
eek readmission rate of 14%, a one-month readmission rate of
7% and an overall readmission of 69% of patients. These results
re perfectly comparable with those found in the standard care
roup in our study, considering 30 day readmission (42%) and
e global readmissions (71%). We are sure that these data are
ufﬁcient to reject the idea of A.J. Wigg et al. that the standard
aregiving model in our study was below the average. We would
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